The Cross-Talk Between the Dopaminergic and the Immune System Involved in Schizophrenia
Dopamine is one of the neurotransmitters whose transmission is altered in a number of neural pathways in the brain of schizophrenic patients. Current evidence indicates that these alterations involve hyperactive dopaminergic transmission in mesolimbic areas, striatum, and hippocampus, whereas hypoac...
Main Authors: | Pia M. Vidal, Rodrigo Pacheco |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00394/full |
Similar Items
-
Altered features of monocytes in adult onset leukoencephalopathy with axonal spheroids and pigmented glia: A clue to the pathomechanism of microglial dyshomeostasis
by: Hamatani, Mio
Published: (2020) -
Innate Immunity in the Central Nervous System: A Missing Piece of the Autoimmune Encephalitis Puzzle?
by: Robb Wesselingh, et al.
Published: (2019-09-01) -
Peripheral immune tolerance alleviates the intracranial lipopolysaccharide injection-induced neuroinflammation and protects the dopaminergic neurons from neuroinflammation-related neurotoxicity
by: Yang Liu, et al.
Published: (2017-11-01) -
Editorial: Dopaminergic Alterations in Schizophrenia
by: Mark D. Tricklebank, et al.
Published: (2021-03-01) -
The role of dopamine receptors in lymphocytes and their changes in schizophrenia
by: M.A. Penedo, et al.
Published: (2021-03-01)